CHARACTERIZATION OF MHC CLASS II-RESTRICTED T-CELL RECEPTORS FOR T-CELL THERAPY OF HBV INFECTION

被引：0
|
作者：
Schreiber, S. [1 ]
Honz, M. [1 ]
Schiemann, M. [2 ]
Sette, A. [3 ]
Zielinski, C. [1 ]
Protzer, U. [1 ]
Wisskirchen, K. [1 ]
机构：
[1] Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munich, Munich, Germany
[2] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany
[3] La Jolla Inst Immunol, Ctr Infect Dis, La Jolla, CA USA
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
ICLEa19-00
引用
收藏
页码：A10 / A10
页数：1
相关论文
共 50 条
  • [1] CHARACTERIZATION OF MHC CLASS II-RESTRICTED T-CELL RECEPTORS FOR T-CELL THERAPY OF HBV INFECTION
    Schreiber, S.
    Honz, M.
    Schiemann, M.
    Zielinski, C.
    Protzer, U.
    Wisskirchen, K.
    CYTOTHERAPY, 2019, 21 (05) : S10 - S10
  • [2] Characterization of MHC Class II-Restricted T-Cell Receptors for T-Cell Therapy of HBV Infection
    Schreiber, Sophia
    Honz, Melanie
    Schiemann, Matthias
    Sette, Alessandro
    Zielinski, Christina
    Protzer, Ulrike
    Wisskirchen, Karin
    MOLECULAR THERAPY, 2020, 28 (04) : 520 - 520
  • [3] Characterization of a library of 20 HBV-specific MHC class II-restricted T cell receptors
    Schreiber, Sophia
    Honz, Melanie
    Mamozai, Weeda
    Kurktschiev, Peter
    Schiemann, Matthias
    Witter, Klaus
    Moore, Eugene
    Zielinski, Christina
    Sette, Alessandro
    Protzer, Ulrike
    Wisskirchen, Karin
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2021, 23 : 476 - 489
  • [4] Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice
    Lee, MK
    Huang, XL
    Jarrett, BP
    Moore, DJ
    Desai, NM
    Lian, MM
    Markmann, JW
    Deng, SP
    Frank, A
    Singer, A
    Velidedeoglu, E
    Caton, AJ
    Markmann, JF
    TRANSPLANTATION, 2003, 75 (08) : 1415 - 1422
  • [5] MHC CLASS II-RESTRICTED T-CELL-RECEPTORS PROVIDE HELP FOR T-CELL-THERAPY OF HEPATITIS B VIRUS INFECTION
    Schreiber, S.
    Wettengel, J.
    Krey, K.
    Wisskirchen, K.
    Protzer, U.
    HUMAN GENE THERAPY, 2022, 33 (7-8) : A31 - A31
  • [6] The use of bioinformatics for identifying class II-restricted T-cell epitopes
    Bian, HJ
    Reidhaar-Olson, JF
    Hammer, J
    METHODS, 2003, 29 (03) : 299 - 309
  • [7] Isolation of human MHC class II-restricted T cell receptors from the autologous T-cell repertoire with potent anti-leukaemic reactivity
    Weigand, Luise U.
    Liang, Xiaoling
    Schmied, Sabine
    Mall, Sabine
    Klar, Richard
    Stoetzer, Oliver J.
    Salat, Christoph
    Goetze, Katharina
    Mautner, Josef
    Peschel, Christian
    Krackhardt, Angela M.
    IMMUNOLOGY, 2012, 137 (03) : 226 - 238
  • [8] Identification of MHC class II-restricted T-cell epitopes in prostate-specific membrane antigen
    Schroers, R
    Shen, L
    Rollins, L
    Xiao, Z
    Sonderstrup, G
    Slawin, K
    Huang, XF
    Chen, SY
    CLINICAL CANCER RESEARCH, 2003, 9 (09) : 3260 - 3271
  • [9] NO MHC CLASS DISTINCTION BY AN MHC RESTRICTED T-CELL CLONE
    SIMPSON, E
    TOMONARI, K
    MELLOR, A
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 291 - 291
  • [10] COMPARISON OF CLASS I-RESTRICTED AND II-RESTRICTED T-CELL RECOGNITION OF THE IDENTICAL PEPTIDE
    PERKINS, DL
    BERRIZ, G
    WANG, YS
    SMITH, JA
    GEFTER, ML
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (11) : 2781 - 2789
12345